Cabot Corporation (NYSE:CBT) Receives Average Rating of “Reduce” from Brokerages

Cabot Corporation (NYSE:CBT) has earned an average recommendation of “Reduce” from the five analysts that are presently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $63.6667.

CBT has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. reduced their target price on Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a report on Friday, November 28th. UBS Group reduced their price objective on shares of Cabot from $82.00 to $65.00 and set a “neutral” rating for the company in a research note on Wednesday, November 5th. Mizuho decreased their target price on shares of Cabot from $78.00 to $72.00 and set an “outperform” rating on the stock in a report on Monday, November 17th. Zacks Research downgraded shares of Cabot from a “hold” rating to a “strong sell” rating in a report on Friday, November 7th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a report on Wednesday, October 8th.

Cabot Stock Up 1.9%

CBT opened at $65.29 on Friday. Cabot has a 12 month low of $58.33 and a 12 month high of $108.93. The company has a market cap of $3.45 billion, a PE ratio of 10.86, a price-to-earnings-growth ratio of 3.36 and a beta of 0.90. The company has a current ratio of 1.61, a quick ratio of 1.08 and a debt-to-equity ratio of 0.50. The company has a 50 day moving average of $66.81 and a 200 day moving average of $73.54.

Cabot (NYSE:CBT) last posted its earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.72 by ($0.02). The company had revenue of $899.00 million for the quarter, compared to analysts’ expectations of $967.02 million. Cabot had a return on equity of 24.55% and a net margin of 8.91%.The company’s revenue was down 10.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.80 EPS. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. On average, sell-side analysts expect that Cabot will post 7.57 EPS for the current year.

Cabot Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 12th. Shareholders of record on Friday, November 28th will be paid a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date is Friday, November 28th. Cabot’s dividend payout ratio is currently 29.95%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of CBT. Norges Bank bought a new stake in shares of Cabot during the 2nd quarter worth $51,710,000. AQR Capital Management LLC raised its position in Cabot by 123.0% during the second quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock valued at $65,096,000 after purchasing an additional 478,702 shares in the last quarter. UBS Group AG lifted its stake in Cabot by 186.7% during the third quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock worth $45,136,000 after purchasing an additional 386,514 shares during the last quarter. American Century Companies Inc. boosted its holdings in shares of Cabot by 13.2% in the 1st quarter. American Century Companies Inc. now owns 1,498,268 shares of the specialty chemicals company’s stock worth $124,566,000 after purchasing an additional 174,921 shares in the last quarter. Finally, Nuveen LLC bought a new position in shares of Cabot during the 1st quarter valued at about $12,365,000. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.